LEARNING OBJECTIVES:

At the conclusion of this activity, participants should be better able to:

• Perform comprehensive patient assessments and manage patient expectations in order to increase patient satisfaction and enhance outcomes.
• Apply the three-dimensional concept of facial volumization and targeting facial zones, rather than specific treatment areas, in order to optimize aesthetic outcomes.
• Recognize the differences among the various HA-based dermal fillers in order to assist in the appropriate selection and placement of these agents.
• Demonstrate protocols and techniques for nonsurgical facial rejuvenation, using HA-based dermal fillers, botulinum toxin and deoxycholic acid in order to improve injection skills, reduce complications, and optimize patient outcomes.

TARGET AUDIENCE:

This program has been developed for dermatologists, plastic surgeons, ophthalmologists as well as other physicians, nurses and physician assistants who have an interest in gaining and/or increasing their knowledge and technical skill to perform facial aesthetic procedures with injectable agents.

FACULTY:

Julie Bass Kaplan, FNP-BC, NP-C, MSN, CANS, CPSN, HCMT, PHN
President, Founder
Disappearing Act Laser & Skin Rejuvenation
JBK Aesthetics
Redding, California

Rebecca Fitzgerald, MD, FAAD
Private Practice
Los Angeles, California

Ellen C. Gendler, MD
Clinical Associate Professor
Department of Dermatology
New York University School of Medicine
New York, New York

Timothy M. Greco, MD, FACS
Adjunct Assistant Professor
Department of Otorhinolaryngology
Division of Facial Plastic Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Private Practice
Bala Cynwyd, Pennsylvania

Steven G. Yoelin, MD
Private Practice
Newport Beach, California

CME Peer Reviewer
Victor B. Hatcher, PhD
Associate Dean
Albert Einstein College of Medicine
Bronx, New York

CONFLICT OF INTEREST STATEMENT

The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine and Montefiore Medical Center requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product or device Company. Any presenter who has disclosed relationships that prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

FACULTY AND PLANNING COMMITTEE DISCLOSURES:

Julie Bass Kaplan, FNP-BC, NP-C, MSN, CANS, CPSN, HCMT, PHN, has received fees for non-CME/CE services from Allergan and Revance Therapeutics, Inc. She has received speaker fees from Allergan and Revance Therapeutics, Inc, and has served as a promotional speaker and board member for these companies. She has an ownership interest in Allergan, Galderma, and Revance Therapeutics, Inc. Julie has disclosed that she intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in her presentation.

Rebecca Fitzgerald, MD, FAAD, has received fees for non-CME/CE services from Allergan, Galderma, and Merz. She has received speaker fees from Allergan, Galderma, and Merz. She has also performed contracted research for Allergan. Dr. Fitzgerald has disclosed that she intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in her presentation.

Ellen C. Gendler, MD, has received fees for non-CME/CE services from Allergan. She has received consultant fees and served as a trainer for Allergan. Dr. Gendler has disclosed that she intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in her presentation.

Timothy M. Greco, MD, FACS, has received fees for non-CME/CE services from Allergan and Galderma. He has received speaker and consulting fees from Allergan and Galderma, and has served as a promotional speaker for these companies. Dr. Greco has disclosed that he intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in his presentation.

Steven G. Yoelin, MD, has received fees for non-CME/CE services from Allergan, Merz, Endo, Evolus, Recros Medica, and Sinclair Pharma Ltd. Dr. Yoelin has received consulting fees from Allergan, Endo, Evolus, Recros Medica, and Sinclair Pharma Ltd, and has performed contracted research for Allergan, Merz, Endo, and Recros Medica. He has also served as a promotional speaker for Allergan. Dr. Yoelin has disclosed that he intends to reference unlabeled/unapproved uses of deoxycholic acid, botulinum toxins, and dermal fillers in his presentation.

Victor B. Hatcher, PhD* has indicated no conflict of interest.

Carol Tucker, MSc (Hons.), CMPP, CHCP, has indicated no conflict of interest.

*CME Peer Reviewer
This CME activity discusses the off-label use of botulinum toxin, HA-based dermal fillers and calcium hydroxylapatite.

AMERICANS WITH DISABILITIES ACT

Albert Einstein College of Medicine-Montefiore Medical Center and the Scientiae, LLC, fully intend to comply with the legal requirements of the Americans with Disabilities Act. If any participant of this activity is in need of special accommodations, please contact PALETTE at least two weeks prior to the activity at 800-401-0291.

SPONSORSHIP STATEMENT:

This activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and Scientiae, LLC

Supported by an educational grant and in-kind contribution of disposable and biological supplies from Allergan Aesthetics, an Abbvie company, and an educational grant for in-kind contribution of disposable and injectable supplies from DermaSculpt by Cosmofrance.

ACCREDITATION STATEMENT:

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and Scientiae, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION STATEMENT:

Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ANCC STATEMENT:

The American Nurses Credentialing Center (ANCC) will accept AMA Category 1 Credits™, on a reciprocal basis, toward their ANCC recertification.

TERM OF APPROVAL:

December 12, 2019 through December 12, 2021

METHOD OF PARTICIPATION:

To receive a maximum of 1.5 AMA PRA Category 1 Credits™ you should:

1. View all the video modules in this CME activity and evaluate the content presented

2. Complete and submit the CME posttest, evaluation form and registration form

SYSTEM REQUIREMENTS

To access activity, users will need:

Chrome, Internet Explorer 11, Microsoft Edge, Firefox , Safari or any other W3C standards compliant browser. An HTML5 capable browser may be required for video or audio playback.

If you are experiencing technical difficulties with accessing this activity, please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. or call us toll-free at 800-401-0291.

STATEMENT REGARDING PRIVACY AND SECURITY OF LEARNER RECORDS

All learner records (including test scores, attendance, evaluations, case studies, and other identified learning materials) shall be kept private and secure, whether in hardcopy or digital format, using a reasonable standard of diligence. In the event of a breach of learner privacy, learners shall be notified immediately. In addition, every effort shall be made to ensure HIPAA compliance of the personal medical privacy of healthcare patients, and study subjects.